Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery (Q24202939)

From Wikidata

Revision as of 01:42, 13 November 2018 by QuickStatementsBot (talk | contribs) (‎Removed claim: author name string (P2093): Maree L Hackett, #quickstatements; #temporary_batch_1538897046242; invoked by sourcemd_batch_processing on behalf of User:Daniel Mietchen (batch 660))

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery	scientific article

Statements

scholarly article

0 references

Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery (English)

0 references

Mansur A Kutlubaev

object named as

Mansur A Kutlubaev

4

0 references

author name string

Gillian E Mead

1

0 references

Cheng-Fang Hsieh

2

0 references

Rebecca Lee

3

0 references

Anne Claxton

5

0 references

Graeme J Hankey

6

0 references

publication date

14 November 2012

0 references

Cochrane Database of Systematic Reviews

0 references

A double blind placebo RCT to investigate the effects of serotonergic modulation on brain excitability and motor recovery in stroke patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Fluoxetine as a treatment for post-stroke emotionalism

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Sertraline in stroke-associated lability of mood

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Influence of Jieyu Huoxue Decoction on rehabilitation of patients with depression after cerebral infarction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

[Interpersonal psychotherapy and pharmacotherapy for post-stroke depression. Feasibility and effectiveness].

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) and fluoxetine on post-stroke depression

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

A double-blind, placebo-controlled study of sertraline in the prevention of depression in stroke patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Mortality and poststroke depression: a placebo-controlled trial of antidepressants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Preventing poststroke depression: a 12-week double-blind randomized treatment trial and 21-month follow-up

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Escitalopram and enhancement of cognitive recovery following stroke

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Incomplete financial disclosure in a study of escitalopram and problem-solving therapy for prevention of poststroke depression

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Fluoxetine improves the quality of life in patients with poststroke emotional disturbances

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Depressive disorders in neurologic rehabilitation: therapy with paroxetine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Clinical Studies on Event-Related Potentials (ERPS) N400 and the Related Factors in Patients with Poststroke Depression (PSD)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Therapeutic effects of milnacipran, a serotonin and noradrenaline reuptake inhibitor, on post-stroke depression

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

A single dose of the serotonin neurotransmission agonist paroxetine enhances motor output: double-blind, placebo-controlled, fMRI study in healthy subjects

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Prediction of the response to citalopram and reboxetine in post-stroke depressed patients.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Fluoxetine vs placebo for depressive symptoms after stroke: failed randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Efficacy of milnacipran on cognitive dysfunction with post-stroke depression: preliminary open-label study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Cognitive improvement after treatment of depressive symptoms in the acute phase of stroke.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Sertraline in the treatment of post-stroke depression--results of an open multicenter study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Citalopram improves dexterity in chronic stroke patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Heterocyclics and selective serotonin reuptake inhibitors in the treatment and prevention of poststroke depression

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Antidepressants in the treatment of stroke

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Treatment effects of antidepressants in patients with post-stroke depression: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Antidepressant prophylaxis for poststroke depression: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Interventions for treating depression after stroke

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Interventions for preventing depression after stroke

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Pharmaceutical interventions for emotionalism after stroke

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Rate, degree, and predictors of recovery from disability following ischemic stroke

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Time frame and predictors of recovery from disability following recurrent ischemic stroke

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Quantifying heterogeneity in a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

State of the art of the neurotrophin hypothesis in psychiatric disorders: implications and limitations

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Fluoxetine affords robust neuroprotection in the postischemic brain via its anti-inflammatory effect

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Cerebral functional magnetic resonance imaging activation modulated by a single dose of the monoamine neurotransmission enhancers fluoxetine and fenozolone during hand sensorimotor tasks.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Adult neurogenesis in the mammalian central nervous system

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Selective serotonin-reuptake inhibitors and recovery after stroke

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Fluoxetine and sertraline attenuate postischemic brain injury in mice

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Meta-analysis of individual patient data from randomized trials: a review of methods used in practice.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Preventing stroke: saving lives around the world

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Pharmacologic treatment of poststroke depression: a systematic review of the literature

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Repairing brain after stroke: a review on post-ischemic neurogenesis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Fluoxetine for the prophylaxis of poststroke depression in patients with stroke: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Preventing Depression After Stroke

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24202939&oldid=788392974"